Condition
Markers of Inflammation
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Early P 1 (1)
Trial Status
Unknown2
Completed1
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07541742Not Yet Recruiting
Health and Nutritional Outcomes Among Young Females and Children in Southwest Bangladesh
NCT07057765Recruiting
Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL
NCT05774613Not ApplicableUnknownPrimary
Effect of Hibiscus Sabdariffa Beverage
NCT03991520Early Phase 1Unknown
Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms
NCT01477645Completed
Health Effects Following Use of Lead Free Ammunition Used With HK416
Showing all 5 trials